DoTerra
 |
|
| Private | |
| Industry | Multi-level marketing |
| Founded | 2008 |
| Headquarters | Pleasant Grove, Utah, United States |
|
Area served
|
International |
|
Key people
|
David Stirling (CEO) Greg Cook, David Hill, Emily Wright, Rob Young, Corey Lindley, Mark Wolfert |
| Products | Essential oils, home products |
|
Number of employees
|
354 |
| Website | www |
doTerra (styled dōTERRA) is a multi-level marketing company based in Pleasant Grove, Utah that sells essential oils and other related products.
doTerra (terra is the Latin word for Earth) was founded in 2008 by David Stirling and former executives, employees, and distributors of Young Living, a company which also sells essential oils, and Nuskin. Stirling is its president and CEO.
As of 2013, doTerra reported about 450 corporate employees; 350 at the Utah headquarters, and 100 at offices in Taiwan, Japan, Europe and in Australia. As of 2016, doTERRA also listed over 3 million independent distributors and salespeople, which the company refers to as "Wellness Advocates." As a multi-level marketing organizations salespeople are expected to recruit other salespeople in order to increase their own profits.
As of 2014, the company sells over 150 products such as supplements, personal care items, and essential oils. Its products are marketed for usage in cooking, cleaning, and health. As of 2013, approximately 75% of the company's business was in the United States.
In August 2013, Young Living filed suit against doTerra for theft of trade secrets, alleging that the company had recreated their production process illegally. Chemist Robert Pappas has said the oils, which were tested by the Centre national de la recherche scientifique, did not match any oils sold by doTerra. One unintended consequence of the lawsuit between the two companies has been a court deposition by Pappas stating that Young Living and doTerra utilizes synthetic chemicals in their organic products. In October 2014 the Fourth District Court dismissed the claims made against doTERRA.
On September 22, 2014, the U.S. Food and Drug Administration issued an FDA Warning Letter to doTerra for marketing its products as possible treatments or cures for Ebola, cancer, autism, and other conditions in violation of the Food, Drug and Cosmetic Act. DoTerra marketing executive McKay Brown released a statement that attempted to distance the company from claims that its “products cure or treat disease including the Ebola virus or any other disease”, and he claimed that they were working to correct marketing materials to ensure compliance with FDA regulations.
...
Wikipedia